Globeflex Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-33,975
Closed -$4.97M 506
2024
Q2
$4.97M Hold
33,975
0.52% 50
2024
Q1
$5.37M Hold
33,975
0.52% 45
2023
Q4
$5.33M Hold
33,975
0.54% 44
2023
Q3
$5.29M Hold
33,975
0.62% 41
2023
Q2
$5.62M Buy
33,975
+5,917
+21% +$955K 0.63% 37
2023
Q1
$4.35M Hold
28,058
0.53% 50
2022
Q4
$4.96M Buy
28,058
+14,800
+112% +$2.56M 0.63% 37
2022
Q3
$2.17M Buy
+13,258
New +$2.24M 0.37% 81
2021
Q4
Sell
-33
Closed -$5K 483
2021
Q3
$5K Hold
33
﹤0.01% 419
2021
Q2
$5K Hold
33
﹤0.01% 434
2021
Q1
$5K Hold
33
﹤0.01% 433
2020
Q4
$5K Hold
33
﹤0.01% 444
2020
Q3
$5K Hold
33
﹤0.01% 439
2020
Q2
$5K Hold
33
﹤0.01% 464
2020
Q1
$4K Hold
33
﹤0.01% 470
2019
Q4
$5K Hold
33
﹤0.01% 467
2019
Q3
$4K Hold
33
﹤0.01% 452
2019
Q2
$5K Buy
+33
New +$4.57K ﹤0.01% 446

Other funds holding JNJ

Globeflex Capital's JNJ Position: Q3 2024 in Review

Globeflex Capital sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 33,975 shares — an estimated $4.97M sold.

Globeflex Capital first reported a position in JNJ in Q2 2019 and held it in 18 quarters. The position peaked at $5.62M in Q2 2023. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Globeflex Capital reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Globeflex Capital sold 33,975 Johnson & Johnson shares in Q3 2024, an estimated $4.97M.
  • Globeflex Capital first reported a position in Johnson & Johnson in Q2 2019 and held it in 18 quarters.
  • Globeflex Capital's Johnson & Johnson position peaked at $5.62M in Q2 2023.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Globeflex Capital's 13F filing for Q3 2024, filed 13 Nov 2024.